1. Home
  2. SHC vs STVN Comparison

SHC vs STVN Comparison

Compare SHC & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotera Health Company

SHC

Sotera Health Company

SELL

Current Price

$17.91

Market Cap

5.2B

Sector

Health Care

ML Signal

SELL

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

SELL

Current Price

$18.90

Market Cap

5.7B

ML Signal

SELL

Company Overview

Basic Information
Metric
SHC
STVN
Founded
2015
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Medical Specialities
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.7B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SHC
STVN
Price
$17.91
$18.90
Analyst Decision
Buy
Buy
Analyst Count
10
14
Target Price
$22.61
★ $24.47
AVG Volume (30 Days)
★ 1.8M
283.5K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
★ 0.33%
EPS Growth
★ 68.75
N/A
EPS
★ 0.28
N/A
Revenue
★ $1,163,617,000.00
N/A
Revenue This Year
$7.16
$6.96
Revenue Next Year
$5.91
$9.15
P/E Ratio
$64.59
★ $27.15
Revenue Growth
★ 5.74
N/A
52 Week Low
$13.09
$12.89
52 Week High
$19.85
$27.99

Technical Indicators

Market Signals
Indicator
SHC
STVN
Relative Strength Index (RSI) 42.82 30.16
Support Level $16.74 $14.23
Resistance Level $18.77 $19.05
Average True Range (ATR) 0.49 0.68
MACD -0.03 -0.14
Stochastic Oscillator 24.83 10.63

Price Performance

Historical Comparison
SHC
STVN

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

About STVN Stevanato Group S.p.A.

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

Share on Social Networks: